ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

NLTX Neoleukin Therapeutics Inc

3.49
0.00 (0.00%)
Apr 25 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -15.17M-15.37M-15.87M-13.61M-14.25M-15.14M-3.07M-5.57M
Pre Tax Income -15.17M-15.35M-15.69M-13.07M-13.45M-14.2M-2.09M-4.53M
Net Income -15.17M-15.35M-15.69M-13.07M-13.45M-14.2M-2.09M-4.53M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -15.17M-15.35M-15.69M-13.65M-14.25M-15.15M-3.07M-5.57M
EBITDA -14.78M-14.95M-15.41M-13.29M-13.88M-11.39M-2.99M-5.49M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 0025M07.83M000
Operating Income -37.65M-51.12M-32.62M-70.96M-33.73M-60.7M-59.1M-55.58M
Pre Tax Income -37M-50.18M-31.59M-69.44M-33.28M-60.69M-57.56M-36.32M
Net Income -37M-50.18M-31.59M-69.44M-33.28M-60.69M-57.56M-36.32M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -1.251-1.694-1.064-1.573-0.688-1.249-1.18-2.336
EBIT -37.69M-51.16M-33.07M-70.97M-33.77M-60.69M-59.14M-39.26M
EBITDA -37.65M-51.12M-32.62M-70.62M-32.94M-59.39M-57.54M-52.29M

Your Recent History

Delayed Upgrade Clock